Company: CI
Filing Date: 2025-09-04
Form Type: 424B5
Source: 0001140361-25-033868
Chunk: 46

Company: Cigna Group
Filing Date: 2025-09-04
Form: 424B5
Chunk 46
---
 the SFA, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA; |

| (2) | where no consideration is or will be given for the transfer; |

| (3) | where the transfer is by operation of law; |

| (4) | as specified in Section 276(7) of the SFA; or |

| (5) | as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore. |

Solely for the purposes of its obligations pursuant to sections 309B(1)(a) and 309B(1)(c) of the SFA, the Company has determined, and hereby notifies all relevant persons (as defined in Section 309A of the SFA) that the Notes are “prescribed capital markets products” (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).

S-27

#### TABLE OF CONTENTS

### VALIDITY OF THE NOTES
The validity of the Notes offered hereby will be passed upon for us by Davis Polk & Wardwell LLP, New York, New York. Paul Hastings LLP, New York, New York, is acting as counsel to the underwriters.

### EXPERTS
The financial statements and management’s assessment of the effectiveness of internal control over financial reporting (which is included in Management’s Annual Report on Internal Control over Financial Reporting) incorporated in this prospectus supplement by reference to the Annual Report on Form 10-K for the year ended December 31, 2024 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

<div align='center'>S-28</div>

#### TABLE OF CONTENTS

### PROSPECTUS

#### The Cigna Group

#### Debt Securities

#### Common Stock

#### Preferred Stock

#### Warrants

#### Purchase Contracts

#### Units
**The Cigna Group may offer and sell the securities listed above from time to time in one or more classes or series and in amounts, at prices and on terms that we